Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Current Treatment Options in Oncology|October 7, 2022
Treatment Options for Recurrent Primary CNS LymphomaLeon D Kaulen, Joachim M BaehringJournal of Neuro-Oncology|July 20, 2020
Autoimmune disease-related primary CNS lymphoma: systematic review and meta-analysisLeon D Kaulen, Philipp Karschnia, Jorg Dietrich, et al.British Journal of Haematology|January 22, 2021
Exome sequencing identifies SLIT2 variants in primary CNS lymphomaLeon D Kaulen, E Zeynep Erson-Omay, Octavian Henegariu, et al.Journal of Neuro-Oncology|June 14, 2019
Prognostic markers for immunodeficiency-associated primary central nervous system lymphomaLeon D Kaulen, Daniela Galluzzo, Pei Hui, et al.Neurology|August 5, 2024
Clinical Presentation, Management, and Outcome in Neurolymphomatosis: A Systematic ReviewLeon D Kaulen, Thomas Hielscher, Sofia Doubrovinskaia, et al.Journal of Neuro-Oncology|August 8, 2024
Factors influencing timely diagnosis in neurolymphomatosisSofia Doubrovinskaia, Antonia Egert, Philipp Karschnia, et al.Neuro-Oncology Practice|April 8, 2020
Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experiencePhilipp Karschnia, Frank J Barbiero, Michaela H Schwaiblmair, et al.European Journal of Neurology|October 19, 2022
Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A follow-up studySofia Doubrovinskaia, Christoph M Mooshage, Corinna Seliger, et al.European Journal of Neurology|October 20, 2021
Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case seriesLeon D Kaulen, Sofia Doubrovinskaia, Christoph Mooshage, et al.Cancer|March 17, 2020
Primary dural lymphomas: Clinical presentation, management, and outcomePhilipp Karschnia, Tracy T Batchelor, Justin T Jordan, et al.Pageof 3